L D Mayer

Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.

L D Mayer, Marcel B. Bally, Helen Loughrey et al. · PubMed · 1990 · 112 citations

Proteinlipid Interaction, Pathology, Cellular Pharmacology +21

Randomized Phase II Study of High-Dose Paclitaxel With or Without Amifostine in Patients With Metastatic Breast Cancer

Karen Gelmon, Elizabeth A. Eisenhauer, C. Bryce et al. · Journal of Clinical Oncology · 1999 · 93 citations

Preclinical toxicology study of liposome encapsulated doxorubicin (TLC D-99): comparison with doxorubicin and empty liposomes in mice and dogs.

Peter M. Kanter, G A Bullard, Frank G. Pilkiewicz et al. · PubMed · 1993 · 57 citations

Lipid Preparation, Tlc D-99, Allergy +14

Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours

L D Mayer, Dana Masin, Rajiv Nayar et al. · British Journal of Cancer · 1995 · 56 citations · Full text

Tumor Biology, Molecular Pharmacology, Drug Targeting +9

The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: Implications for drug delivery

Murray S. Webb, J J Wheeler, Marcel B. Bally et al. · Biochimica et Biophysica Acta (BBA) - Biomembranes · 1995 · 46 citations

Cationic Lipid Stearylamine, Proteinlipid Interaction, Pharmaceutical Science +5